<DOC>
	<DOCNO>NCT01086774</DOCNO>
	<brief_summary>Evaluation optical effect Systane Ultra</brief_summary>
	<brief_title>Efficacy Systane Balance Stabilize Tear Film Dry Eye Subjects</brief_title>
	<detailed_description />
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<mesh_term>Tetrahydrozoline</mesh_term>
	<mesh_term>Lubricant Eye Drops</mesh_term>
	<criteria>1 . Age 18 year . 2 . Subjects must Tear Break Up Time ( TBUT ) &lt; 5 second 3 . Subjects must maximum blink interval ( MBI ) &lt; 10 second 4 . Subjects must willing comply study requirement . 5 . Subjects must understand , sign give copy write Informed Consent form . 1 . Subjects eyes meet inclusion criterion either eye meet exclusion criterion 2 . Subjects pregnant , lactate plan pregnant course study 3 . Subjects know sensitivity plan study concomitant medication 4 . Subjects participate ophthalmic drug device clinical trial within 30 day clinical investigation . 5 . Use ocular drug , study medication , study within 14 day prior study entry ocular medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Dry eye</keyword>
	<keyword>Tear Film Stability</keyword>
</DOC>